Drugs firm examined by regulator after ‘shocking’ safety breaches

The Health Products Regulatory Authority (HPRA) said it was concerned and was “following up with" drug maker Astellas

Susan Mitchell

Deputy Editor and Health Editor @susmitchellsbp
2nd July, 2017

Ireland’s medicines regulator is assessing the possible implications for Ireland after the drugmaker Astellas was accused of “shocking” breaches of guidelines that “raised serious concerns with regard to patient safety” in Britain.

In a statement to this newspaper last week, the Health Products Regulatory Authority (HPRA) said it was concerned and was “following up with Astellas as regards any possible implications for the advertising and promotion of the company’s...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Analysis: Variants and vaccines make projecting path of virus more complex

Health Rachel Lavin 1 day ago

HSE’s latest private hospitals Covid deal estimated to cost €47 million a month

Health Daniel Murray 6 days ago

Key public health posts remain vacant

Health Daniel Murray 6 days ago

Breakdown of HSE’s €1.6 billion war chest to fight Covid-19

Health Daniel Murray 6 days ago